Corrigendum to Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway Atherosclerosis (373), May 2023, 29-37
Puntos clave
Sirt4 deficiency enhances inflammation, driving atherosclerosis development with significant implications.
Key findings indicate that levels of CXCL2 and CXCL3 were notably increased in contrasting groups.
Analysis utilized the NF-κB/IκB signaling pathway to explore the molecular mechanisms involved.
Findings highlight the need for further studies to validate potential therapeutic targets in atherosclerosis.
Corrigendum to Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway Atherosclerosis (373), May 2023, 29-37 | Synapse